Effects of Health Promoting Programs on Cardiovascular Disease Risk
Effects of Health-Promoting Programs on Cardiovascular Disease Risk: JHS
調査の概要
状態
状態
条件
条件
介入・治療
介入・治療
詳細な説明
The project is designed to achieve five specific aims: (1) To determine the feasibility of attracting African Americans into Health Promotion Research studies;(2) To determine whether clinically recorded information can be used as a guide for recruitment inclusion in Health Promotion Studies from an active epidemiological research cohort;(3) To measure the ability to retain African Americans recruited into Health Promotion Studies from an active research cohort;(4) To measure the adherence to various protocols within a Health promotion Study; and(5) To provide informed estimates of effect sizes for designing future Health Promotion Research.
A total of 375 study participants from the Jackson Heart Study (JHS) cohort, all of whom are African American, will be randomly assigned to one of five, equally-sized study arms: (1) practicing yoga three times per week; (2) practicing yoga two times per week; (3) practicing yoga one time per week; (4) walking briskly three times per week; and (5) attending a weekly healthy lifestyles class.
All study arms will include a 24-week intervention. In addition, participants will have a total of four clinical visits with members of the study team baseline, 12 weeks, 24 weeks, and 48 weeks) in which the following measures will be recorded:
- Systolic and diastolic blood pressure and heart rates
- Highly sensitive C-reactive protein (hsCRP) - serum, fibrinogen - plasma (sodium citrate), homocysteine (plasma), and interleukin-6 levels (IL-6) (serum).
- Fasting total cholesterol, low density (LDL), direct high density lipoprotein (HDL), and triglyceride levels - all serum
- HbA1c level
- BMI, waist circumference
- Medication and supplement use and dosages
- Results of a study survey designed to measure participants' changes in their reported health-related quality of life, perceived stress, health behaviors, sleep patterns, and impact of pain on everyday life
In addition, we will also record systolic and diastolic blood pressure and heart rates before and after each intervention session for all five study arms.
研究の種類
研究の種類
入学 (実際)
入学
段階
段階
- 適用できない
連絡先と場所
研究場所
-
-
Mississippi
-
Jackson、Mississippi、アメリカ、39216
- University of Mississippi Medical Center
-
-
参加基準
適格基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- This study includes only one inclusion criterion: to participate in this study, one needs to be a member of the Jackson Heart Study cohort.
Exclusion Criteria:
1. Newly diagnosed (within the last six weeks) with a myocardial infarction, cerebrovascular disease, atrial fibrillation, cardiomyopathy, valvular heart disease, fatal cardiac arrhythmia, severe systolic and diastolic heart failure, uncontrolled COPD, uncontrolled moderate to severe hypertension, or a recent recipient of a pacemaker, and/or
2. Change in blood pressure medicine or lipid-lowering medication up to 30 days prior to or plans for a change in the 30 days after enrollment in the study, and/or
3. Already practicing yoga at least once per week or walking briskly for one hour at least three times per week, and/or
4. Inability to attend protocol sessions, and/or
5. Diagnosis of an underlying medical illness that might be considered by the principal investigator to potentially impair one's safety or ability to complete the study protocol (example could possibly include uncontrolled asthma), and/or
6. Current use of a prescription regimen that might be considered by the principal investigator to potentially impair one's safety or ability to complete the study protocol (examples could possibly include use of sedatives or other drugs that could affect a participant's ability to participate in any of the study arms).
7. Pregnant or planning to become pregnant in the next six (6) months.
研究計画
研究はどのように設計されていますか？
デザインの詳細
- 主な目的：他の
- 割り当て：ランダム化
- 介入モデル：並列代入
- マスキング：独身
アーム数
武器と介入
参加者グループ / アーム参加者グループ / アーム |
介入・治療介入・治療 |
|---|---|
|
他の：Yoga 3 times per week
Yoga participation 3 x per week for 24 weeks; 48 week follow-up.
|
The yoga intervention, which is taught based on Hatha yoga, will be offered to study participants in Study Arms 1, 2, and 3, is a combination of asanas (poses), pranayams (breathing exercises), and meditation.
Blood pressure and heart rate measurements are taken before and after each session.
|
|
他の：Yoga 2 times per week
Yoga participation 2 x per week for 24 weeks; 48 week follow-up
|
The yoga intervention, which is taught based on Hatha yoga, will be offered to study participants in Study Arms 1, 2, and 3, is a combination of asanas (poses), pranayams (breathing exercises), and meditation.
Blood pressure and heart rate measurements are taken before and after each session.
|
|
他の：Yoga 1 time per week
Yoga participation 1 x per week for 24 weeks; 48 week follow-up
|
The yoga intervention, which is taught based on Hatha yoga, will be offered to study participants in Study Arms 1, 2, and 3, is a combination of asanas (poses), pranayams (breathing exercises), and meditation.
Blood pressure and heart rate measurements are taken before and after each session.
|
|
他の：Walking 3 times per week
Walking 3x per week for 24 weeks; 48 week follow-up
|
The walking intervention, which is Study Arm 4 includes, three guided walking sessions per week for 24 weeks.
Each class is an hour in length and will include a minimum of 30 minutes of walking at the equivalent of a minimum of three miles per hour.
Each session includes a ten-minute warm-up and ten-minute cool-down period of some stretches and walking at a leisurely pace.
Blood pressure and heart rate measurements are taken before and after each session.
|
|
他の：Healthy Lifestyles Education
Healthy Lifestyles Education Participation 1 x per week for 24 weeks; 48 week follow-up
|
Participants randomly assigned to the fifth study arm attend one 60-minute healthy lifestyles class per week for 24 weeks.
The Healthy Lifestyles curriculum includes 24 independent lesson modules, which allows participants to begin their intervention at any time during the course schedule.
Blood pressure and heart rate measurements are taken before and after each session.
他の名前：
|
この研究は何を測定していますか？
主要な結果の測定
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Primary outcomes for this feasibility study will focus on composite measures for recruitment, retention, and the reasons for refusal or dropout.
時間枠：Bi-annual for up to 52 weeks after enrollment
|
Primary outcomes for this feasibility study will focus on measures for recruitment, retention, and the reasons for refusal or dropout, and consist of (1) agreement to participate in the study (recruitment); (2) reasons for participating/not-participating; (3) dropout, defined as a monotone missingness pattern of stopping participation before completion of the study; (4) reasons for discontinuation/dropout; (5) attendance, defined as the potentially non-monotone pattern of coming to the scheduled study session; and (6) adherence, defined as attending and completing the scheduled sessions and clinical visits.
|
Bi-annual for up to 52 weeks after enrollment
|
二次結果の測定
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Changes in participants' hypertension profiles.
時間枠：48 weeks
|
Defined using measures of their systolic and diastolic blood pressure
|
48 weeks
|
|
Changes in participants' inflammation markers
時間枠：48 weeks
|
Defined using measures of participants' hsCRP, fibrinogen, homocysteine, and interleukin-6 levels.
|
48 weeks
|
|
Changes in participants' lipids profiles.
時間枠：48 weeks
|
Defined as using measures of participants' fasting total cholesterol, LDL, HDL, and triglycerides.
|
48 weeks
|
|
Changes in participants' HbA1c levels.
時間枠：48 weeks
|
Changes in participants' HbA1c levels.
|
48 weeks
|
|
Changes in participants' reported health-related quality of life.
時間枠：48 weeks
|
Quality of life measured as measured by perceived stress, health behaviors, sleep patterns, and impact of pain on everyday life.
|
48 weeks
|
協力者と研究者
捜査官
捜査官
- 主任研究者：Gailen D Marshall, MD, PhD、University of Mississippi Medical Center
研究記録日
主要日程の研究
研究開始
研究開始
一次修了 (実際)
一次修了
研究の完了 (実際)
研究の完了
試験登録日
最初に提出
最初に提出
QC基準を満たした最初の提出物
QC基準を満たした最初の提出物
最初の投稿 (見積もり)
最初の投稿
学習記録の更新
投稿された最後の更新 (実際)
投稿された最後の更新
QC基準を満たした最後の更新が送信されました
QC基準を満たした最後の更新が送信されました
最終確認日
最終確認日
詳しくは
本研究に関する用語
追加の関連 MeSH 用語
その他の研究ID番号
その他の研究ID番号
- 2010-0057
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。